User profiles for Einar August Høgestøl
 | Einar August HøgestølOslo University Hospital Verified email at medisin.uio.no Cited by 878 |
[HTML][HTML] Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19
AH Aamodt, EA Høgestøl, TH Popperud, JC Holter… - Journal of …, 2021 - Springer
Objective To test the hypotheses that blood biomarkers for nervous system injury, serum
concentrations of neurofilament light chain protein (NfL) and glial fibrillary acidic protein (GFAp) …
concentrations of neurofilament light chain protein (NfL) and glial fibrillary acidic protein (GFAp) …
[HTML][HTML] Quantitative proteomic analyses of CD4+ and CD8+ T cells reveal differentially expressed proteins in multiple sclerosis patients and healthy controls
T Berge, A Eriksson, IS Brorson, EA Høgestøl… - Clinical proteomics, 2019 - Springer
Background Multiple sclerosis (MS) is an autoimmune, neuroinflammatory disease, with an
unclear etiology. However, T cells play a central role in the pathogenesis by crossing the …
unclear etiology. However, T cells play a central role in the pathogenesis by crossing the …
[HTML][HTML] Symptoms of fatigue and depression is reflected in altered default mode network connectivity in multiple sclerosis
Background Fatigue and depression are frequent and often co-occurring symptoms in multiple
sclerosis (MS). Resting-state functional magnetic resonance imaging (rs-fMRI) represents …
sclerosis (MS). Resting-state functional magnetic resonance imaging (rs-fMRI) represents …
[HTML][HTML] T cell responses to SARS-CoV-2 vaccination differ by disease-modifying therapy for multiple sclerosis
Immune responses in people with multiple sclerosis (pwMS) receiving disease-modifying
therapies (DMTs) have been of significant interest throughout the COVID-19 pandemic. …
therapies (DMTs) have been of significant interest throughout the COVID-19 pandemic. …
Risk of fingolimod rebound after switching to cladribine or rituximab in multiple sclerosis
…, H Torgauten, L Skattebøl, EA Høgestøl… - Multiple Sclerosis and …, 2022 - Elsevier
… Einar August Høgestøl received honoraria for lecturing and advisory board activity from
Biogen, Merck and Sanofi-Genzyme and unrestricted research grant from Merck. Piotr Sowa has …
Biogen, Merck and Sanofi-Genzyme and unrestricted research grant from Merck. Piotr Sowa has …
Supplementary motor area syndrome after surgery for parasagittal meningiomas
J Berg-Johnsen, EA Høgestøl - Acta Neurochirurgica, 2018 - Springer
Background Resection within the supplementary motor area (SMA) may be accompanied
by dramatic motor deficits and speech arrest when the dominant hemisphere is involved, …
by dramatic motor deficits and speech arrest when the dominant hemisphere is involved, …
[HTML][HTML] Quantitative proteomics reveals protein dysregulation during T cell activation in multiple sclerosis patients compared to healthy controls
…, IS Brorson, IS Leikfoss, O Kråbøl, EA Høgestøl… - Clinical Proteomics, 2022 - Springer
Background Multiple sclerosis (MS) is an autoimmune, neurodegenerative disorder with a
strong genetic component that acts in a complex interaction with environmental factors for …
strong genetic component that acts in a complex interaction with environmental factors for …
Functional connectivity in multiple sclerosis modelled as connectome stability: A 5-year follow-up study
EA Høgestøl, S Ghezzo, GO Nygaard… - Multiple Sclerosis …, 2022 - journals.sagepub.com
Background: Brain functional connectivity (FC) in multiple sclerosis (MS) is abnormal
compared to healthy controls (HCs). More longitudinal studies in MS are needed to evaluate …
compared to healthy controls (HCs). More longitudinal studies in MS are needed to evaluate …
T cell responses to SARS-CoV-2 vaccination in people with multiple sclerosis differ between disease-modifying therapies
Immune responses in people with multiple sclerosis (pwMS) on disease-modifying therapies
(DMTs) have been of significant interest throughout the COVID-19 pandemic. Lymphocyte-…
(DMTs) have been of significant interest throughout the COVID-19 pandemic. Lymphocyte-…
Lesion Volume as a Predictor for Return to Work After Endovascular Therapy-a Four-year Prospective Cohort Study
Background: There are no known objective biomarkers for predicting Return to Work (RTW)
in ischemic stroke survivors. This study aims to explore the predictive utility and define a cut-…
in ischemic stroke survivors. This study aims to explore the predictive utility and define a cut-…
